Fig. 3: Prognostic analysis with tumour-infiltrating lymphocytes (TILs) in intra-tumour of ICCs.

a CD8+ TILs, b FoxP3+ TILs, c combination of CD8+ and FoxP3+ TILs and d FoxP3+/CD8+ TIL ratio.

a CD8+ TILs, b FoxP3+ TILs, c combination of CD8+ and FoxP3+ TILs and d FoxP3+/CD8+ TIL ratio.